Putative uncharacterized protein ORFH in retron EC67 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
antibody; Putative uncharacterized protein ORFH in retron EC67 antibody
Uniprot No.

Q&A

What is a retron and how does it relate to ORFH protein?

Retrons are bacterial genetic retroelements that encode reverse transcriptase enzymes capable of producing multicopy single-stranded DNA (msDNA). These elements function as part of bacterial antiphage defense systems. The ORFH protein is a specific component found within the retron EC67 system, which belongs to a group of tripartite systems comprising a reverse transcriptase, non-coding RNA genes, and effector proteins .

The retron complex plays a critical role in sensing and recognizing invading phages, subsequently activating effector proteins that can induce abortive infection strategies to protect the bacterial cell. ORFH functions within this system, though its precise molecular mechanism remains under investigation. Current evidence suggests it may be involved in the regulatory aspects of retron activation or in the downstream signaling pathways that lead to phage resistance .

How do retrons function in bacterial immune responses?

Retrons function as sophisticated components of bacterial defense systems against phage infection. When a phage infects a bacterial cell, the retron system can detect specific phage-encoded proteins (such as helicases) and activate an immune response. This detection mechanism triggers the retron-associated effector proteins, leading to an abortive infection strategy that sacrifices the infected cell to protect the broader bacterial population .

Recent research has revealed that retrons can specifically detect phage components like the UvsW and D10 helicases (found in phages T4 and T5, respectively). Upon detection, the retron complex activates the toxicity of the effector protein bound to it, triggering cell death or growth arrest before the phage can complete its replication cycle . The ORFH protein is believed to participate in this defense pathway, possibly by interacting with specific phage components or by mediating downstream signaling events.

What are the structural characteristics of the ORFH protein?

The ORFH protein belongs to a family of retron-associated proteins that often contain specific structural domains. Based on comparative analysis with similar retron-associated proteins, ORFH likely contains:

  • A potential DNA-binding domain, possibly a winged helix-turn-helix (HTH) motif that aligns structurally with transcriptional regulators

  • A conserved C-terminal tail (CTT) which may be divided into a hypervariable C-terminal linker and a conserved C-terminal peptide sequence

  • Structural similarity to other retron-associated proteins that form part of bacterial immunity complexes

Sequence analysis suggests ORFH contains approximately 169 amino acids with specific functional regions that contribute to its role in the retron system . The protein's structure likely facilitates its interaction with other components of the retron complex and potentially with phage-derived molecules during infection.

What are optimal methods for isolating and characterizing ORFH protein?

The isolation and characterization of ORFH protein requires specific methodological approaches:

Protein Expression and Purification Protocol:

  • Recombinant expression systems: The protein can be expressed in E. coli, yeast, baculovirus, or mammalian cell systems, with mammalian expression generally yielding properly folded protein with appropriate post-translational modifications

  • Purification techniques: Antigen-affinity chromatography is recommended for antibody purification, while protein purification should achieve >85% purity as determined by SDS-PAGE

  • Storage considerations: The recombinant protein should be reconstituted in deionized sterile water to a concentration of 0.1-1.0 mg/mL with 5-50% glycerol (final concentration) added for long-term storage at -20°C/-80°C

For characterization, a combination of western blotting (for protein detection and size verification), ELISA (for quantification and antibody reactivity testing), and functional assays (to assess biological activity) provides comprehensive analysis of the ORFH protein .

How can researchers design experiments to analyze ORFH function in retron-mediated immunity?

To investigate ORFH function in retron-mediated immunity, researchers should consider the following experimental design framework:

  • Genetic manipulation approaches:

    • Gene knockout/knockdown studies to observe phenotypic changes in bacterial phage resistance

    • Complementation assays to verify the specific function of ORFH

    • Domain mutagenesis to identify critical functional regions

  • Interaction studies:

    • Co-immunoprecipitation experiments to identify protein binding partners

    • Bacterial two-hybrid or pull-down assays to characterize protein-protein interactions

    • Chromatin immunoprecipitation (ChIP) if DNA-binding activities are suspected

  • Phage challenge experiments:

    • Controlled infection assays with various phages to determine specificity

    • Measurement of bacterial survival rates in wild-type versus ORFH-mutant strains

    • Time-course analysis of retron activation following phage infection

These experimental approaches should be complemented with appropriate controls and statistical analysis to ensure robust and reproducible results.

What quality control measures are essential when working with ORFH antibodies?

When working with ORFH antibodies, implementing rigorous quality control measures is critical:

Quality Control ParameterRecommended MethodAcceptance Criteria
Antibody specificityWestern blot against purified ORFH and bacterial lysatesSingle band at expected molecular weight; minimal cross-reactivity
SensitivityTitration ELISADetection limit ≤10 ng of target protein
Batch-to-batch consistencyComparative western blot and ELISA<15% variation in signal intensity
Cross-reactivityTesting against related proteins<5% cross-reactivity with non-target proteins
Application validationTesting in intended applications (WB, ELISA)Consistent performance across applications

For ORFH antibodies specifically, validation should include testing against Escherichia coli samples known to contain the retron EC67, as well as negative controls lacking this genetic element. The antibody isotype (typically IgG for rabbit-derived antibodies) should be verified, and purification methods (typically antigen-affinity) should be documented .

How does the retron EC67 system compare with other retron systems in bacterial defense?

Retron EC67 represents one of several distinct retron systems that function in bacterial defense. Comparative analysis reveals:

  • Structural classification:

    • Retron EC67 (also known as Retron-Eco2) belongs to type I-C1 classification with a clade 8 reverse transcriptase

    • This contrasts with other systems like Retron-Eco11, which is classified as type III-A3 and contains a clade 9 reverse transcriptase

  • Effector mechanisms:

    • Different retron systems employ varied effector proteins; while EC67 contains ORFH, other systems like Retron-Eco11 utilize phosphoribosyltransferase (PRTase)-like effectors fused to DNA-binding domains

    • The activation mechanisms may differ, with EC67 potentially responding to different phage triggers than other retron systems

  • Evolutionary relationships:

    • Phylogenetic analysis suggests retron-associated effectors represent distinct lineages within their protein families

    • The ORFH protein in EC67 shows evolutionary adaptations specific to its role in defense against particular phage types

Understanding these comparative aspects helps researchers contextualize their findings when studying the ORFH protein and its role within the broader landscape of bacterial immunity systems.

What mechanisms do phages employ to counter retron-based bacterial defenses?

Phages have evolved sophisticated counter-defense strategies against retron-mediated bacterial immunity:

  • tRNA supplementation strategy:

    • Some phages (such as T5 family) encode tRNA molecules that can replace bacterial tRNAs degraded by retron effectors

    • For example, phages provide tRNA^Tyr to counter the activity of retron 78's effector protein (ptuAB) which specifically degrades this tRNA

  • Anti-defense protein expression:

    • Phages encode specific anti-retron proteins, such as Rad (retron anti-defense)

    • Rad functions by degrading the non-coding RNA components of retrons, which are precursors to the msDNA essential for retron function

  • Temporal regulation mechanisms:

    • Some phages may evade retron detection through careful temporal regulation of gene expression

    • Early-expressed phage genes may trigger retron activation, while other phages might evolve to delay expression of triggering factors

These phage counter-defense mechanisms represent an ongoing evolutionary arms race between bacteria and their viral predators, with significant implications for researchers studying ORFH and related retron components.

How might ORFH protein function in biotechnological applications?

The potential biotechnological applications of ORFH and related retron proteins extend beyond their natural roles:

  • Gene editing platform development:

    • Similar to how retrons have been harnessed in Retron Library Recombineering (RLR), ORFH could potentially be engineered as part of novel genetic manipulation tools

    • RLR enables millions of genetic experiments to be performed simultaneously, with retron sequences serving as barcodes that identify mutant strains

  • Phage resistance engineering:

    • Understanding ORFH's role in retron-mediated immunity could inform the development of enhanced bacterial strains with programmable phage resistance

    • This has applications in biotechnology industries that rely on bacterial cultures vulnerable to phage contamination

  • Diagnostic tool development:

    • Antibodies against ORFH could be utilized in diagnostic assays to identify specific bacterial strains harboring the retron EC67 system

    • This might have applications in environmental monitoring or microbiome research

Each of these applications requires thorough understanding of ORFH's structure-function relationships and careful optimization of experimental conditions to achieve desired outcomes.

What sequencing approaches are most effective for studying retron RT-DNA?

The analysis of retron-derived reverse transcriptase DNA (RT-DNA) requires specialized sequencing approaches:

  • Sample preparation:

    • RT-DNA containing reads should be exported as FASTA files

    • Assembly should be performed using software like Geneious, starting at known landmarks (such as promoter sequences) and extending through the retron-RT region

  • Coverage analysis:

    • Calculate percentage coverage by dividing reads at each nucleotide by the total number of reads containing RT-DNA

    • This provides insight into the efficiency and specificity of reverse transcription within the retron system

  • Terminal base bias assessment:

    • Combine oligonucleotides in equal parts to a total concentration of 1 μM as controls

    • Prepare for sequencing using the same method as retron-derived RT-DNA

    • Analyze with custom scripts to identify sequences of interest, allowing for mismatches including undefined terminal bases

These specialized techniques enable researchers to accurately characterize the molecular products of retron activity, providing insights into how ORFH and other components function within the retron complex.

How should researchers interpret contradictory results in retron studies?

When encountering contradictory results in studies involving ORFH and retron systems, researchers should systematically evaluate:

  • Strain and genetic background variation:

    • Different bacterial strains may contain variant retron systems with distinct regulatory mechanisms

    • Genetic background effects can significantly influence retron function and ORFH activity

  • Experimental condition differences:

    • Phage challenge conditions (MOI, timing, phage strain) can dramatically affect outcomes

    • Growth conditions, media composition, and environmental factors may alter retron activation thresholds

  • Methodological considerations:

    • Protein expression systems (bacterial, yeast, mammalian) may produce ORFH variants with different functional properties

    • Antibody specificity and sensitivity can vary between sources and batches

  • Interpretation framework:

    • Retron systems likely represent diverse defense mechanisms that have evolved independently

    • Apparent contradictions may reflect genuine biological diversity rather than experimental error

When publishing findings, researchers should clearly document all experimental conditions and genetic backgrounds to facilitate accurate replication and comparison across studies.

What are the critical controls for validating ORFH antibody specificity?

Validating the specificity of antibodies against ORFH protein requires comprehensive controls:

  • Positive control panel:

    • Purified recombinant ORFH protein at known concentrations

    • Bacterial lysates from strains confirmed to express ORFH

    • Transfected mammalian cells expressing tagged ORFH constructs

  • Negative control panel:

    • Lysates from bacterial strains lacking the retron EC67 element

    • Closely related proteins from the same family to test cross-reactivity

    • Pre-immune serum controls for polyclonal antibodies

  • Validation experiments:

    • Western blot analysis with sample titration to establish detection limits

    • Immunoprecipitation followed by mass spectrometry to confirm target identity

    • Competitive binding assays with purified ORFH to demonstrate specificity

  • Application-specific controls:

    • For ELISA: Establish standard curves using purified ORFH

    • For Western blot: Include molecular weight markers and loading controls

    • For immunofluorescence: Include secondary antibody-only controls

Proper validation ensures that experimental results reflect true ORFH biology rather than non-specific antibody interactions or technical artifacts.

What are the most promising avenues for research on ORFH and retron systems?

Several high-priority research directions hold particular promise for advancing understanding of ORFH and retron systems:

  • Structural biology approaches:

    • Determining the three-dimensional structure of ORFH through X-ray crystallography or cryo-EM

    • Characterizing ORFH's interaction with other retron components and phage proteins

    • Investigating structural changes during retron activation

  • Systems biology integration:

    • Mapping the complete interaction network of ORFH within bacterial cells

    • Understanding how retron systems integrate with other bacterial defense mechanisms

    • Characterizing the evolutionary relationships between diverse retron systems

  • Therapeutic and biotechnological applications:

    • Developing ORFH-based systems for programmable gene editing

    • Exploring potential antimicrobial strategies based on phage-resistance mechanisms

    • Engineering synthetic retron systems with novel functionalities

  • Comparative genomics:

    • Large-scale analysis of retron distribution across bacterial species

    • Identifying novel ORFH variants with potential unique functions

    • Tracking the co-evolution of retrons and phage counter-defense mechanisms

Progress in these areas will require interdisciplinary collaboration and integration of advanced molecular techniques with computational approaches.

How might recent advances in gene editing impact research on retron-based systems?

Recent gene editing advances create new opportunities for retron research:

  • Integration with CRISPR technologies:

    • Combining retron systems with CRISPR-Cas tools could overcome limitations of both platforms

    • CRISPR can provide targeting specificity while retrons offer efficient DNA template delivery

    • This integration could reduce off-target effects associated with Cas9

  • High-throughput screening applications:

    • Retron Library Recombineering (RLR) enables millions of mutations to be screened simultaneously

    • The barcode functionality of retrons allows pooled screening approaches that dramatically accelerate discovery

    • ORFH variants could potentially be engineered to enhance these capabilities

  • Methodological innovations:

    • New techniques for retron RT-DNA sequencing and analysis

    • Improved protein expression systems for producing functional ORFH protein

    • Advanced imaging techniques to visualize retron dynamics in living cells

These advances suggest that retron-based systems, including those involving ORFH, may become increasingly important tools in molecular biology, potentially complementing or even competing with established CRISPR-based approaches in certain applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.